1[1]Thuillez C, Richard C, Loueslati H. The hemodynamic action of perindopril in patient with congestive heart failure. J Cardiovasc Pharmacol, 1990, 15:527
2[2]MacFadyen R J, Lees KR, Reid JL. A placebo controlled trial of ACE inhibitor in refractory chronic congestive heart failure.University of Glasgow. Br Heart, 1991, 66:206
3[3]Iain B. Squire MB. Long-term tolerance and effect of perinodoril to patient with chronic congestive heart failure. Clin Cardiol.1996, 19 (Suppl 1):9-15
4[4]Jones JV. Perindopril. The British Journal of Cardiology,1998, 5(5):268
5[5]Schoenberger JA. Converting enzyme inhibitors in the treatment of hypertension. In: Punzi HA, Flamenbaum W, eds. Hypertension Volume J. New York: Futura Publishing, 1989: 155-166
同被引文献8
1陈修.心血管药理学[M].北京:人民卫生出版社,1997.514.
2Van de ven PJ, Beutler JJ, Kaatee R, et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease[J]. Kidney Int, 1998,53 (4): 986 - 993.
3WHO/ISH.高血压诊断标准与分级.中国校医,2001,15(1).
4Thuillez C, Richard C, Loueslati H.The hemodynamic action of perindopril in patient with congestive heart failure. J CardiovascPharmacol , 1990, 15: 527.
5Mac Fadyen R J, Lees KR, Reid JL. A placebocontrolled trial of ACE inhibitor in refractory chronic congestive heart failure University of Glasgow[J]. Br Heart, 1991,66:206.
